STICTG Logo  

All STI CTG Protocols

 
invisible image
line
line
line
line
line
line
line
line
line
line
line
line
line
line
line

 

Email page link:

1 pix

STI CTG Protocols

Since its inception in 2005, the STI CTG has received a total of 89 Concepts. Each Concept was reviewed by the Executive Committee for responsiveness to the STI CTG mission. Concepts consistent with the STI CTG mission were then assessed by the Scientific Review Committee.

3 protocols are pending submission to the STI CTG

4 protocols are under development (1 protocol in collaboration)
4 studies are actively enrolling participants

5 studies are closed to enrollment/completed
Currently, the network is facilitating 16 studies in various stages
 

Status
Title

Pending

Submission

GenProbe APTIMA Trichomonas Test - Progression to 510(k)
   
Pending Submission A RCT of Single vs. Multiple (3 Weekly) Dose Benzathine Penicillin G for Early Syphilis Therapy of Persons With and Without HIV.
   
Development on Hold A non-inferiority trial of oral therapy (cefpodoxime 400mg & azithromycin 1gm) compared with intramuscular therapeutic injection (ceftriaxone 125mg) for treatment of pharyngeal gonorrhea
   
Development on Hold Randomized Trial of Patient Delivered Partner Therapy vs. Standard Partner Referral for Prevention of Persistent or Recurrent Chlamydial Infection
   

In Development

Phase 0 Demonstration project of an STI e-Health System for STI Diagnosis and Treatment
   

In Development

Self-Obtained Vaginal Swabs for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae
   
Enrolling Preventing Vaginal Infections in Women at Risk for HIV-1
   
Enrolling Randomized Clinical Trial Evaluating Efficacy of Gentamicin/Azithromycin and Gemifloxacin/Azithromycin and Combination Therapies as a Salvage Regimen for Uncomplicated Urogenital Gonorrhea
   
Enrolling Randomized Clinical Trial Evaluating Treatment Failure Following Recommended Therapy (Azithromycin versus Doxycycline) for Genital Chlamydial Infection in Females in Youth Correctional Facilities
   
Enrolling Home Screening for Bacterial Vaginosis to Prevent STDs
   
Closed to Enrollment Randomized Trial to Evaluate the Need for Empiric Therapy for Mucopurulent Cervicitis of Unknown Etiology
   
Completed Phase II Randomized, Placebo-Controlled Double-Blind 4-arm Trial for the Treatment of Non-Gonococcal urethritis (NGU): Doxycycline (Plus or Minus Tinidazole) Verses Azithromycin (Plus or Minus Tinidazole)
   

Completed

A Phase III Equivalence Trial of Azithromycin vs. Benzathine Penicillin for the Treatment of Early Syphilis
   
Completed Assessing recruitment and enrollment strategies for STI studies
   
Completed An Expanded Phase I Randomized Placebo Controlled Trial of the Safety and Tolerability of 3% w/w SPL7013 Gel (VivaGelâ„¢) in Healthy Young Women When Administered Twice Daily for 14 Days
   

 


 
1 px
Partners Logo
© Copyright 2010, STI Clinical Trials Group (STICTG)
invisible